ZEMA Pharma Consulting ApS: Financial statements 2023
CVR: 42680427
Source: annual report 2023, Danish Business Authority
01/10/2022 – 30/09/2023
ZEMA Pharma Consulting ApS (CVR 42680427) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,472,110 and a net result of DKK 812,354 compared with DKK 789,558 the year before. That is an increase of 28.4% compared with the year before. Equity in the 2023 report amounted to DKK 852,912. The solvency ratio was 53.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,472,110
- Profit/Loss
- DKK 812,354
- Equity
- DKK 852,912
- Total Assets
- DKK 1,586,535
- Employees
- 1
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout ZEMA Pharma Consulting ApS
ZEMA Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Dyssegård, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Mads Torkild Hansen. The company is owned by Mads Torkild Hansen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 102,227 and a net result of DKK -216,744 compared with DKK -281,625 the year before. Equity in the 2025 report amounted to DKK 354,543.
